Profile image
Visiting Professorial Fellow

Dr Mark Boyd

Phone
+61 (2) 9385 0900
E-mail
mboyd@kirby.unsw.edu.au
Karran EL; Cashin AG; Barker T; Boyd MA; Chiarotto A; Mohabir V; Petkovic J; Sharma S; Tugwell P; Moseley GL, 2024, 'Development of recommendations for a minimum dataset for Identifying Social factors that Stratify Health Opportunities and Outcomes (ISSHOOs) in pain research.', MethodsX, 12, pp. 102496, http://dx.doi.org/10.1016/j.mex.2023.102496
2024
McMichael G; Cusack L; Andina Munawar D; Boyd M; Palmer L; Lim HS; Mahajan R, 2024, 'Atrial Fibrillation Health Literacy Questionnaire (AFHLQ): The development of an AF-specific health literacy questionnaire', IJC Heart and Vasculature, 50, http://dx.doi.org/10.1016/j.ijcha.2023.101322
2024
Smithers LG; MacPhail C; Chan L; Downes M; Neadley K; Boyd M, 2024, 'In-person versus electronic screening for social risks among carers of pediatric inpatients: A mixed methods randomized trial', European Journal of Pediatrics, 183, pp. 2301 - 2309, http://dx.doi.org/10.1007/s00431-024-05470-1
2024
Harney BL; Sacks-Davis R; Agius P; van Santen DK; Traeger MW; Wilkinson AL; Asselin J; Fairley CK; Roth N; Bloch M; Matthews GV; Donovan B; Guy R; Stoové M; Hellard ME; Doyle JS; Aung HL; Baillie G; Bastian L; Bateson D; Boyd M; Carter A; Cogle A; Costello J; Dimech W; El-Hayek C; Ellard J; Franklin L; Hocking J; Kim J; Nguyen L; Nguyen T; Nolan D; O’Connor C; Patel P; Pendle S; Polkinghorne V; Reed P; Ryder N; Selvey C; Walker M; Watson N, 2024, 'Risk of Primary Incident Hepatitis C Infection Following Bacterial Sexually Transmissible Infections Among Gay and Bisexual Men in Australia From 2016 to 2020', Open Forum Infectious Diseases, 11, http://dx.doi.org/10.1093/ofid/ofae099
2024
Edwards S; Puljević C; Dean JA; Gilks C; Boyd MA; Baker P; Watts P; Howard C; Gartner CE, 2023, 'Tobacco Harm Reduction with Vaporised Nicotine (THRiVe): A Feasibility Trial of Nicotine Vaping Products for Smoking Cessation Among People Living with HIV', AIDS and Behavior, 27, pp. 618 - 627, http://dx.doi.org/10.1007/s10461-022-03797-0
2023
Poirier BF; Ribeiro Santiago PH; Kapellas K; Jamieson L; Neadley KE; Boyd M, 2023, 'Development of Social Determinants of Health Screening Tool (SDoHST): qualitative validation with stakeholders and patients in South Australia', Current Medical Research and Opinion, 39, pp. 131 - 140, http://dx.doi.org/10.1080/03007995.2022.2144053
2023
Karran EL; Cashin AG; Barker T; Boyd MA; Chiarotto A; Dewidar O; Petkovic J; Sharma S; Tugwell P; Moseley GL, 2023, 'The ‘what’ and ‘how’ of screening for social needs in healthcare settings: a scoping review', PeerJ, 11, http://dx.doi.org/10.7717/peerj.15263
2023
Heron JE; McManus H; Vickers T; Ryan K; Wright E; Carter A; Stoove M; Asselin J; Grulich A; Donovan B; Guy R; Varma R; Chen M; Ryder N; Lewis DA; Templeton DJ; O’Connor CC; Gracey DM; Bastian L; Bateson D; Bowden S; Boyd M; Callander D; Aung HL; Cogle A; Costello J; Dimech W; Dittmer J; El-Hayek C; Ellard J; Fairley C; Franklin L; Hellard M; Hocking J; Kim J; McGill S; Nolan D; Patel P; Pendle S; Polkinghorne V; Nguyen L; Nguyen T; Reed P; Roth N; Selvey C; Traeger M; Walker M; West M, 2023, 'Renal impairment associated with tenofovir disoproxil fumarate for antiretroviral therapy and HIV pre-exposure prophylaxis: An observational cohort study', PLoS ONE, 18, http://dx.doi.org/10.1371/journal.pone.0280339
2023
Stretton B; Kovoor J; Gupta A; Hains L; Bacchi S; Wong B; O'Callaghan PG; Barreto S; Hugh TJ; Murphy E; Trochsler M; Padbury R; Boyd M; Maddern G, 2023, 'Get out what you put in: optimising electronic medical record data', ANZ Journal of Surgery, 93, pp. 2056 - 2058, http://dx.doi.org/10.1111/ans.18559
2023
Stretton B; Kovoor J; Bacchi S; Booth A; Gluck S; Vanlint A; Afzal M; Ovenden C; Gupta A; Mahajan R; Edwards S; Brennan Y; Boey JP; Reddi B; Maddern G; Boyd M, 2023, 'Impact of perioperative direct oral anticoagulant assays: a multicenter cohort study', Hospital Practice, 51, pp. 155 - 162, http://dx.doi.org/10.1080/21548331.2023.2206270
2023
Mascaro S; Wu Y; Woodberry O; Nyberg EP; Pearson R; Ramsay JA; Mace AO; Foley DA; Snelling TL; Nicholson AE; Semprini A; Martin A; McLean-Tooke A; Marais B; Tang B; McLeod C; Blyth CC; Lemoh C; Waddington C; Nolan D; Raby E; Perez G; Marks G; Denholm J; Pilgram L; Anstey N; Plebanski M; Boyd M; Borland ML; Maze M; John M; Middleton P; Craig S; Tong SYC; Benson S; Richards T, 2023, 'Modeling COVID-19 disease processes by remote elicitation of causal Bayesian networks from medical experts', BMC Medical Research Methodology, 23, http://dx.doi.org/10.1186/s12874-023-01856-1
2023
Taylor SL; Papanicolas LE; Flynn E; Boyd MA; Wesselingh SL; Rogers GB, 2023, 'Preventing empirical antibiotic treatment failure in migrant populations: screening by infection risk, not ethnic background', International Journal of Infectious Diseases, 134, pp. 168 - 171, http://dx.doi.org/10.1016/j.ijid.2023.06.014
2023
Stretton B; Tran V; Kovoor JG; Gupta AK; Bacchi S; Maddern GJ; Boyd M, 2023, 'Phone home: The translational benefits of space medicine for rural and remote perioperative medicine on Earth', Australian Journal of Rural Health, 31, pp. 782 - 784, http://dx.doi.org/10.1111/ajr.12995
2023
Stretton B; Kovoor J; Bacchi S; Chang S; Ngoi B; Murray T; Bristow TC; Heng J; Gupta A; Ovenden C; Maddern G; Thompson CH; Heilbronn L; Boyd M; Rayner C; Talley NJ; Horowtiz M, 2023, 'Weight loss with subcutaneous semaglutide versus other glucagon-like peptide 1 receptor agonists in type 2 diabetes: a systematic review', Internal Medicine Journal, 53, pp. 1311 - 1320, http://dx.doi.org/10.1111/imj.16126
2023
Stretton B; Kovoor J; Bacchi S; Gupta A; Hugh T; Dobbins C; Trochsler M; Hewett P; Chan WO; Barreto SG; Rayner C; Bruening M; Padbury R; Talley NJ; Anthony A; Horowitz M; Maddern G; Boyd M, 2023, 'Like a Surgeon? A letter commenting on Grosse and Thomas's ‘Selection into training will always be an inexact process: a survey of Directors of Physician Education on selection into Basic Physician Training in Australia and New Zealand’', Internal Medicine Journal, 53, pp. 1724 - 1725, http://dx.doi.org/10.1111/imj.16214
2023
Stretton B; Eranki A; Kovoor J; Bacchi S; Gupta A; Maddern G; Boyd M, 2023, 'Too Sour to be True? Tart Cherries (Prunus cerasus) and Sleep: a Systematic Review and Meta-analysis', Current Sleep Medicine Reports, 9, pp. 225 - 233, http://dx.doi.org/10.1007/s40675-023-00261-w
2023
Karran EL; Cashin AG; Barker T; Boyd MA; Chiarotto A; Dewidar O; Mohabir V; Petkovic J; Sharma S; Tejani S; Tugwell P; Moseley GL, 2023, 'Using PROGRESS-plus to identify current approaches to the collection and reporting of equity-relevant data: a scoping review', Journal of Clinical Epidemiology, 163, pp. 70 - 78, http://dx.doi.org/10.1016/j.jclinepi.2023.09.017
2023
Dawson AP; Warrior E; Pearson O; Boyd MA; Dwyer J; Morey K; Brodie T; Towers K; Waters S; Avila C; Hammond C; Lake KJ; Lampard F; Wanganeen F; Bennell O; Bromley D; Shearing T; Rigney N; Czygan S; Clinch N; Pitson A; Brown A; Howard NJ, 2023, 'Exploring self-determined solutions to service and system challenges to promote social and emotional wellbeing in Aboriginal and Torres Strait Islander people: a qualitative study', Frontiers in Public Health, 11, http://dx.doi.org/10.3389/fpubh.2023.1206371
2023
Stretton B; Kovoor J; Bacchi S; Gupta A; Edwards S; Boey JP; Gluck S; Reddi B; Maddern G; Boyd M, 2023, 'Quantifying time from last dose: do direct oral anticoagulant assays correlate with patient's reported last dose', Blood Coagulation and Fibrinolysis, 34, pp. 451 - 455, http://dx.doi.org/10.1097/MBC.0000000000001254
2023
Stretton B; Harford P; Kovoor J; Bacchi S; Gupta A; Sandhu J; Moran H; Edwards S; Jacobsen JHW; Maddern G; Boyd M, 2023, 'Association between direct oral anticoagulant concentrations and clinical outcomes: A systematic review and meta-analysis', Surgery in Practice and Science, 15, http://dx.doi.org/10.1016/j.sipas.2023.100230
2023
Freeman T; Fisher M; Foley K; Boyd MA; Ward PR; McMichael G; Zimmermann A; Dekker G, 2022, 'Barriers to digital health services among people living in areas of socioeconomic disadvantage: Research from hospital diabetes and antenatal clinics', Health Promotion Journal of Australia, 33, pp. 751 - 757, http://dx.doi.org/10.1002/hpja.540
2022
Lathlean T; Kieu D; Franke KB; O'Callaghan N; Boyd MA; Mahajan R, 2022, 'Impact of health literacy and its interventions on health outcomes in those with atrial fibrillation: A systematic review protocol', BMJ Open, 12, http://dx.doi.org/10.1136/bmjopen-2022-065407
2022
Lake KJ; Boyd MA; Smithers L; Howard NJ; Dawson AP, 2022, 'Exploring the readiness of senior doctors and nurses to assess and address patients’ social needs in the hospital setting', BMC Health Services Research, 22, http://dx.doi.org/10.1186/s12913-022-07642-x
2022
Lake KJ; Boyd MA; Smithers L; Howard NJ; Dawson AP, 2022, 'Correction to: Exploring the readiness of senior doctors and nurses to assess and address patients’ social needs in the hospital setting (BMC Health Services Research, (2022), 22, 1, (246), 10.1186/s12913-022-07642-x)', BMC Health Services Research, 22, http://dx.doi.org/10.1186/s12913-022-07758-0
2022
Walls A; Boyd M; McMichael G; Smithers LG, 2022, 'Can social risks in early life predict children's health and academic outcomes? An analysis of the Longitudinal Study of Australian Children', SSM - Population Health, 17, http://dx.doi.org/10.1016/j.ssmph.2022.101070
2022
Harney BL; Sacks-Davis R; Van Santen DK; Traeger M; Wilkinson AL; Asselin J; El-Hayek C; Fairley CK; Roth N; Bloch M; Matthews G; Donovan B; Guy R; Stoové M; Hellard ME; Doyle JS; Bastian L; Bateson D; Bowden S; Boyd M; Callander D; Carter A; Cogle A; Costello J; Dimech W; Dittmer J; Ellard J; Franklin L; Kim J; Mcgill S; Nolan D; Patel P; Pendle S; Polkinghorne V; Nguyen L; Nguyen T; O'connor C; Reed P; Ryder N; Selvey C; Vickers T; Walker M; Watchirs-Smith L; West M, 2022, 'The Incidence of Hepatitis C Among Gay, Bisexual, and Other Men Who Have Sex With Men in Australia, 2009-2019', Clinical Infectious Diseases, 74, pp. 1804 - 1811, http://dx.doi.org/10.1093/cid/ciab720
2022
Traeger MW; Guy R; Asselin J; Patel P; Carter A; Wright EJ; Grulich A; McManus H; Fairley CK; Chow EPF; McNulty A; Finlayson R; Bell C; Owen L; Marshall L; Russell D; O'Donnell D; Donovan B; Hellard ME; Stoové MA; Bastian L; Bateson D; Bowden S; Boyd M; Callander D; Cogle A; Costello J; Dimech W; Dittmer J; El-Hayek C; Ellard J; Franklin L; Hocking J; Kim J; McGill S; Nolan D; Pendle S; Polkinghorne V; Nguyen L; Nguyen T; O'Connor C; Reed P; Roth N; Ryder N; Selvey C; Vickers T; Walker M; Watchirs-Smith L; West M, 2022, 'Real-world trends in incidence of bacterial sexually transmissible infections among gay and bisexual men using HIV pre-exposure prophylaxis (PrEP) in Australia following nationwide PrEP implementation: an analysis of sentinel surveillance data', The Lancet Infectious Diseases, 22, pp. 1231 - 1241, http://dx.doi.org/10.1016/S1473-3099(22)00175-X
2022
Lau A; Kong FYS; Fairley CK; Templeton DJ; Amin J; Phillips S; Law M; Chen MY; Bradshaw CS; Donovan B; McNulty A; Boyd MA; Timms P; Chow EPF; Regan DG; Khaw C; Lewis DA; Kaldor J; Ratnayake M; Carvalho N; Hocking JS, 2021, 'Azithromycin or doxycycline for asymptomatic rectal chlamydia trachomatis', New England Journal of Medicine, 384, pp. 2418 - 2427, http://dx.doi.org/10.1056/NEJMoa2031631
2021
Mwasakifwa GE; Amin J; Kelleher A; Boyd MA, 2021, 'Inflammatory biomarkers and soft tissue changes among patients commencing second-line antiretroviral therapy after first-line virological failure', AIDS, 35, pp. 2289 - 2298, http://dx.doi.org/10.1097/QAD.0000000000003014
2021
Patel PG; Keen P; McManus H; Duck T; Callander D; Selvey C; Power C; Gray RT; Knight V; Asselin J; Read P; Johnson K; Bavinton BR; Bowden VJ; Grulich AE; Guy R; Prestage G; Zablotska I; Holden J; Cooper C; Price K; Holt M; de Wit J; Kaldor J; Kelleher A; Wilson D; Brotherton A; Cooper DA; Crooks L; Whittaker B; Madeddu D; Schmidt HM; Telfer B; Price K; Boyd M; McGill S; Pinto A; Nigro S; Gordon T; Feeney L; Cunningham P; Mao L; Gray J; O’Dwyer M; Clifton B, 2021, 'Increased targeted HIV testing and reduced undiagnosed HIV infections among gay and bisexual men', HIV Medicine, 22, pp. 605 - 616, http://dx.doi.org/10.1111/hiv.13102
2021
Neadley KE; McMichael G; Freeman T; Browne-Yung K; Baum F; Pretorius E; Taylor K; Boyd MA, 2021, 'Capturing the social determinants of health at the individual level: A pilot study', Public Health Research and Practice, 31, http://dx.doi.org/10.17061/PHRP30232008
2021
Rattanakosit T; Franke K; Munawar DA; Page AJ; Boyd MA; Lau DH; Mahajan R, 2021, 'Role of Indices Incorporating Power, Force and Time in AF Ablation: A Systematic Review of Literature', Heart Lung and Circulation, 30, pp. 1379 - 1388, http://dx.doi.org/10.1016/j.hlc.2021.04.007
2021
Chakraborty A; Pearson O; Schwartzkopff KM; O'rourke I; Ranasinghe I; Mah PM; Adams R; Boyd M; Wittert G, 2021, 'The effectiveness of in-hospital interventions on reducing hospital length of stay and readmission of patients with Type 2 Diabetes Mellitus: A systematic review', Diabetes Research and Clinical Practice, 174, http://dx.doi.org/10.1016/j.diabres.2020.108363
2021
Nyein PP; Aung E; Aung NM; Kyi MM; Boyd M; Lin KS; Hanson J, 2021, 'The impact of gender and the social determinants of health on the clinical course of people living with HIV in Myanmar: an observational study', AIDS Research and Therapy, 18, pp. 50, http://dx.doi.org/10.1186/s12981-021-00364-w
2021
Mak G; Zaunders JJ; Bailey M; Seddiki N; Rogers G; Leong L; Phan TG; Kelleher AD; Koelsch KK; Boyd MA; Danta M, 2021, 'Preservation of Gastrointestinal Mucosal Barrier Function and Microbiome in Patients With Controlled HIV Infection', Frontiers in Immunology, 12, pp. 688886, http://dx.doi.org/10.3389/fimmu.2021.688886
2021
Di Giallonardo F; Pinto AN; Keen P; Shaik A; Carrera A; Salem H; Selvey C; Nigro SJ; Fraser N; Price K; Holden J; Lee FJ; Dwyer DE; Bavinton BR; Geoghegan JL; Grulich AE; Kelleher AD; Guy R; Prestage G; Zablotska I; Holden J; Duck T; Cooper C; Holt M; de Wit J; Kaldor J; Wilson D; Brotherton A; Cooper DA; Crooks L; Whittaker B; Callander D; Madeddu D; Schmidt HM; Telfer B; Boyd M; McGill S; Patel P; Power C; Gordon T; Feeney L; Bath K; Mackie B, 2021, 'Subtype-specific differences in transmission cluster dynamics of HIV-1 B and CRF01_AE in New South Wales, Australia', Journal of the International AIDS Society, 24, pp. e25655, http://dx.doi.org/10.1002/jia2.25655
2021
Khaw C; Zablotska-Manos I; Boyd MA, 2021, 'Men who have Sex with Men and Chemsex: A Clinic-Based Cross-sectional Study in South Australia', Sexuality Research and Social Policy, 18, pp. 1014 - 1022, http://dx.doi.org/10.1007/s13178-020-00505-2
2021
Ashokan A; Hanson J; Aung NM; Kyi MM; Taylor SL; Choo JM; Flynn E; Mobegi F; Warner MS; Wesselingh SL; Boyd MA; Rogers GB, 2021, 'Investigating potential transmission of antimicrobial resistance in an open-plan hospital ward: a cross-sectional metagenomic study of resistome dispersion in a lower middle-income setting', Antimicrobial Resistance and Infection Control, 10, pp. 56, http://dx.doi.org/10.1186/s13756-021-00915-w
2021
Jiamsakul A; Boyd M; Choi JY; Edmiston N; Kumarasamy N; Hutchinson J; Law M; Ditangco R, 2021, 'Trends in Follow-Up Visits among People Living with HIV: Results from the TREAT Asia and Australian HIV Observational Databases', Journal of Acquired Immune Deficiency Syndromes, 88, pp. 70 - 78, http://dx.doi.org/10.1097/QAI.0000000000002725
2021
Vannakit R; Andreeva V; Mills S; Cassell MM; Jones MA; Murphy E; Ishikawa N; Boyd MA; Phanuphak N, 2020, 'Fast-tracking the end of HIV in the Asia Pacific region: domestic funding of key population-led and civil society organisations', The Lancet HIV, 7, pp. e366 - e372, http://dx.doi.org/10.1016/S2352-3018(20)30077-1
2020
Ramachandran J; Kaambwa B; Muller K; Haridy J; Tse E; Tilley E; Altus R; Waddell V; Gordon D; Shaw D; Huynh D; Stewart J; Nelson R; Warner M; Boyd MA; Chinnaratha MA; Harding D; Ralton L; Colman A; Woodman R; Wigg AJ, 2020, 'Cost effectiveness of treatment models of care for hepatitis C: The South Australian state-wide experience', European Journal of Gastroenterology and Hepatology, 32, pp. 1381 - 1389, http://dx.doi.org/10.1097/MEG.0000000000001659
2020
Lau A; Kong FYS; Fairley CK; Templeton DJ; Amin J; Boyd MA; Bradshaw C; Chen MY; Donovan B; Khaw C; Lewis DA; McNulty A; Regan DG; Ratnayake M; Hocking JS, 2020, 'Factors Associated with Early Resumption of Condomless Anal Sex among Men Who Have Sex with Men after Rectal Chlamydia Treatment', Sexually Transmitted Diseases, 47, pp. 389 - 394, http://dx.doi.org/10.1097/olq.0000000000001166
2020
Yang F; Janamnuaysook R; Boyd MA; Phanuphak N; Tucker JD, 2020, 'Key populations and power: people-centred social innovation in Asian HIV services', The Lancet HIV, 7, pp. e69 - e74, http://dx.doi.org/10.1016/S2352-3018(19)30347-9
2020
Mwasakifwa GE; Amin J; White CP; Center JR; Kelleher A; Boyd MA, 2020, 'Early changes in bone turnover and inflammatory biomarkers and clinically significant bone mineral density loss over 48 weeks among HIV-infected patients with virological failure of a standard first-line antiretroviral therapy regimen in the SECOND-LINE study', HIV Medicine, 21, pp. 492 - 504, http://dx.doi.org/10.1111/hiv.12882
2020
Vannakit R; Andreeva V; Mills S; Cassell MM; Jones MA; Murphy E; Ishikawa N; Boyd MA; Phanuphak N, 2020, 'HIV programmes in countries within the Asia-Pacific region – Authors' reply', The Lancet HIV, 7, pp. e530 - e531, http://dx.doi.org/10.1016/S2352-3018(20)30210-1
2020
Khaw C; Malden C; Ratnayake M; Boyd M, 2020, 'Diagnosis and Management of Syphilis in Patients With HIV Co-infection', Current Treatment Options in Infectious Diseases, 12, pp. 215 - 226, http://dx.doi.org/10.1007/s40506-020-00225-6
2020
Denholm JT; Davis J; Paterson D; Roberts J; Morpeth S; Snelling T; Zentner D; Rees M; O'Sullivan M; Price D; Bowen A; Tong SYC; Denholm J; Anderson S; McQuilton Z; Venkatesh B; Hammond N; Jha V; Burston VJ; McMahon J; Charles P; Commons R; O'Brien D; Mahoney A; Sheffield D; Lim LL; Gardiner B; Schulz T; Torresi J; Chean R; Sasadeusz J; Rogers B; Aboltins C; Singh K; Yong M; Lister D; Visvanathan K; Molton J; Tai A; Chalmers R; Martinello M; Wilson P; Gray T; Coghill S; Foo H; Sud A; Williams J; Lwin N; Post J; Van Haal S; Sullivan R; Matthews G; Kwan BCH; Slack A; Shum O; Cochrane B; Dotel R; Gilbey T; Mina M; Su Y; Trethewy C; Hudson B; Chatterji A; Mostert C; New D; Raby E; Hui S; Robinson O; Hart J; Tan SJ; Arellano A; Chambers J; Davis J; Rafiei N; Smith S; Sehu M; Da Silva J; Griffin P; Henderson A; Chaw K; Choong K; Burke A; Heather C; Senanayake S; Boyd M; Rowe E; Anagnostou M; Trad A; Ratcliff A; Dummer J; Bhally H; Giola M; Grimwade K; Chang CLL; Verrall A; Hogg S; Restropo D; Maze M; Ritchie S; Gedye C, 2020, 'The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trial', Trials, 21, http://dx.doi.org/10.1186/s13063-020-04576-9
2020
Thomson S; Doan T; Liu D; Schubert KO; Toh J; Boyd MA; Galletly C, 2020, 'Supporting the vulnerable: developing a strategic community mental health response to the COVID-19 pandemic', Australasian Psychiatry, 28, pp. 492 - 499, http://dx.doi.org/10.1177/1039856220944701
2020
McManus H; Callander D; Donovan B; Russell DB; O'Connor CC; Davies SC; Lewis DA; Hellard ME; Chen MY; Petoumenos K; Varma R; Cogle A; Boyd MA; Grulich A; Pollard J; Medland N; Fairley CK; Guy RJ, 2019, 'Early initiation of antiretroviral therapy for people newly diagnosed with HIV infection in Australia: trends and predictors, 2004–2015', Medical Journal of Australia, 210, pp. 269 - 275, http://dx.doi.org/10.5694/mja2.50006
2019
Boyd MA; Boffito M; Castagna A; Estrada V, 2019, 'Rapid initiation of antiretroviral therapy at HIV diagnosis: definition, process, knowledge gaps', HIV Medicine, 20, pp. 3 - 11, http://dx.doi.org/10.1111/hiv.12708
2019
Melaku YA; Gill TK; Appleton SL; Hill C; Boyd MA; Adams RJ, 2019, 'Sociodemographic, lifestyle and metabolic predictors of all-cause mortality in a cohort of community-dwelling population: An 18-year follow-up of the North West Adelaide Health Study', BMJ Open, 9, http://dx.doi.org/10.1136/bmjopen-2019-030079
2019
Bell SK; Mena G; Dean J; Watts P; Howard C; Boyd M; Gilks C; Gartner C, 2019, 'Addressing smoking among people living with HIV: a cross-sectional survey of Australian HIV health practitioners’ practices and attitudes', AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, 31, pp. 436 - 442, http://dx.doi.org/10.1080/09540121.2018.1500007
2019
Ramachandran J; Kaambwa B; Muller K; Haridy J; Tse E; Tilley E; Waddell V; Gordon D; Shaw D; Nelson R; boyd M; Warner M; Ralton L; Colman A; stewart J; Harding D; Chinnaratha A; Woodman R; Huynh D; Wigg A, 2019, 'FRI-200-Spend less get more;cost effectiveness of various models of care in hepatitis C treatment', Journal of Hepatology, 70, pp. e479 - e479, http://dx.doi.org/10.1016/s0618-8278(19)30945-4
2019
Stockdale AJ; Saunders MJ; Boyd MA; Bonnett LJ; Johnston V; Wandeler G; Schoffelen AF; Ciaffi L; Stafford K; Collier AC; Paton NI; Geretti AM, 2018, 'Effectiveness of Protease Inhibitor/Nucleos(t)ide Reverse Transcriptase Inhibitor-Based Second-line Antiretroviral Therapy for the Treatment of Human Immunodeficiency Virus Type 1 Infection in Sub-Saharan Africa: A Systematic Review and Meta-analysis', Clinical Infectious Diseases, 66, pp. 1846 - 1857, http://dx.doi.org/10.1093/cid/cix1108
2018
Giles ML; Gartner C; Boyd MA, 2018, 'Smoking and HIV: What are the risks and what harm reduction strategies do we have at our disposal?', AIDS Research and Therapy, 15, http://dx.doi.org/10.1186/s12981-018-0213-z
2018
Yao AH; Moore CL; Lim PL; Molina JM; Madero JS; Kerr S; Mallon PWG; Emery S; Cooper DA; Boyd MA, 2018, 'Metabolic profiles of individuals switched to second-line antiretroviral therapy after failing standard first-line therapy for treatment of HIV-1 infection in a randomized, controlled trial', Antiviral Therapy, 23, pp. 21 - 32, http://dx.doi.org/10.3851/IMP3171
2018
Wright E; Grulich A; Roy K; Boyd M; Cornelisse V; Russell D; O'Donnell D; Whittaker B; Crooks L; Zablotska I, 2018, 'Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine HIV pre-exposure prophylaxis: clinical guidelines. Update April 2018', Journal of Virus Eradication, 4, pp. 143 - 159, http://dx.doi.org/10.1016/s2055-6640(20)30260-0
2018
Haridy J; Wigg A; Muller K; Ramachandran J; Tilley E; Waddell V; Gordon D; Shaw D; Huynh D; Stewart J; Nelson R; Warner M; Boyd M; Chinnaratha MA; Harding D; Ralton L; Colman A; Liew D; Iyngkaran G; Tse E, 2018, 'Real-world outcomes of unrestricted direct-acting antiviral treatment for hepatitis C in Australia: The South Australian statewide experience', Journal of Viral Hepatitis, 25, pp. 1287 - 1297, http://dx.doi.org/10.1111/jvh.12943
2018
Wright E; Grulich A; Roy K; Boyd M; Cornelisse V; Russell D; O'Donnell D; Whittaker B; Crooks L; Zablotska I, 2018, 'Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine HIV pre-exposure prophylaxis: clinical guidelines. Update April 2018.', J Virus Erad, 4, pp. 143 - 159, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892678/
2018
Mwasakifwa GE; Moore C; Carey D; Amin J; Penteado P; Losso M; Lim PL; Mohapi L; Molina JM; Gazzard B; Cooper DA; Boyd M, 2018, 'Relationship between untimed plasma lopinavir concentrations and virological outcome on second-line antiretroviral therapy', AIDS, 32, pp. 357 - 361, http://dx.doi.org/10.1097/QAD.0000000000001688
2018
Boyd MA; Cooper DA, 2018, 'Combination ART: are two drugs as good as three?', The Lancet, 391, pp. 817 - 819, http://dx.doi.org/10.1016/S0140-6736(18)30008-4
2018
Wright E; Grulich A; Roy K; Boyd M; Cornelisse V; Russell D; O'Donnell D; Whittaker B; Crooks L; Zablotska I, 2018, 'Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine HIV pre-exposure prophylaxis: clinical guidelines. Update April 2018.', Journal of Virus Eradication, 4, pp. 143 - 159
2018
Boyd MA; Cooper DA; Gilks CF, 2018, 'Towards a universal second-line fixed-dose combination ART', The Lancet HIV, 5, pp. e3 - e5, http://dx.doi.org/10.1016/S2352-3018(17)30180-7
2018
Haridy J; Wigg A; Muller K; Ramachandran J; Tilley E; Waddell V; Gordon D; Shaw D; Huynh D; Stewart J; Nelson R; Warner M; Boyd M; Chinnaratha A; Harding D; Ralton L; Colman A; Iyngkaran G; Tse E, 2018, 'Outcomes of direct-acting antiviral therapy for chronic hepatitis C following unrestricted access in Australia: Real-world outcomes from the state of South Australia', Journal of Hepatology, 68, pp. S265 - S265, http://dx.doi.org/10.1016/s0168-8278(18)30743-8
2018
Boyd MA; Amin J; Mallon PWG; Kumarasamy N; Lombaard J; Wood R; Chetchotisakd P; Phanuphak P; Mohapi L; Azwa I; Belloso WH; Molina JM; Hoy J; Moore CL; Emery S; Cooper DA, 2017, 'Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE study', The Lancet HIV, 4, pp. e13 - e20, http://dx.doi.org/10.1016/S2352-3018(16)30189-8
2017
Aung NM; Hanson J; Kyi TT; Htet ZW; Cooper DA; Boyd MA; Kyi MM; Saw HA, 2017, 'HIV care in Yangon, Myanmar; successes, challenges and implications for policy', AIDS Research and Therapy, 14, pp. 10, http://dx.doi.org/10.1186/s12981-017-0137-z
2017
Puhr R; Petoumenos K; Youds D; Law MG; Templeton DJ; Ellis D; Bloch M; Agrawal S; Vincent T; Allen D; Smith D; Rankin A; Baker D; O'Connor CC; Thackeray O; Jackson E; McCallum K; Ryder N; Sweeney G; Cooper D; Carr A; Macrae K; Hesse K; Finlayson R; Gupta S; Langton-Lockton J; Shakeshaft J; Brown K; Idle S; Arvela N; Varma R; Lu H; Couldwell D; Eswarappa S; Smith DE; Furner V; Cabrera G; Fernando S; Cogle A; Lawrence C; Mulhall B; Boyd M; Law M; Huang R; Han A; Gunathilake M; Payne R; O'Sullivan M; Croydon A; Russell D; Cashman C; Roberts C; Sowden D; Taing K; Marshall P; Orth D; Rowling D; Latch N; Warzywoda E; Dickson B; Donohue W; Moore R; Edwards S; Boyd S; Roth NJ; Lau H; Read T; Silvers J; Zeng W; Hoy J; Watson K; Bryant M; Price S; Woolley I; Giles M; Korman T; Williams J; Nolan D; Allen A; Guelfi G; Mills G; Wharry C; Raymond N; Bargh K, 2017, 'The impact of changes in HIV management guidelines on time to treatment initiation in Australia', HIV Medicine, 18, pp. 701 - 703, http://dx.doi.org/10.1111/hiv.12504
2017
Bell S; Dean J; Gilks C; Boyd MA; Fitzgerald L; Mutch A; Baker P; Neilsen G; Gartner CE, 2017, 'Tobacco harm reduction with vaporised nicotine (THRiVe): The study protocol of an uncontrolled feasibility study of novel nicotine replacement products among people living with HIV who smoke', International Journal of Environmental Research and Public Health, 14, http://dx.doi.org/10.3390/ijerph14070799
2017
Lau A; Kong F; Fairley CK; Donovan B; Chen M; Bradshaw C; Boyd M; Amin J; Timms P; Tabrizi S; Regan DG; Lewis DA; McNulty A; Hocking JS, 2017, 'Treatment efficacy of azithromycin 1 g single dose versus doxycycline 100 mg twice daily for 7 days for the treatment of rectal chlamydia among men who have sex with men - a double-blind randomised controlled trial protocol', BMC Infectious Diseases, 17, pp. 35, http://dx.doi.org/10.1186/s12879-016-2125-7
2017
Petoumenos K; Choi JY; Hoy J; Kiertiburanakul S; Ng OT; Boyd M; Rajasuriar R; Law M; Han A, 2017, 'CD4:CD8 ratio comparison between cohorts of HIV-positive Asians and Caucasians upon commencement of antiretroviral therapy', Antiviral Therapy, 22, pp. 659 - 668, http://dx.doi.org/10.3851/IMP3155
2017
Rhee SY; Varghese V; Holmes SP; Van Zyl GU; Steegen K; Boyd MA; Cooper DA; Nsanzimana S; Saravanan S; Charpentier C; de Oliveira T; Etiebet MAA; Garcia F; Goedhals D; Gomes P; Günthard HF; Hamers RL; Hoffmann CJ; Hunt G; Jiamsakul A; Kaleebu P; Kanki P; Kantor R; Kerschberger B; Marconi VC; D'amour Ndahimana J; Ndembi N; Ngo-Giang-Huong N; Rokx C; Santoro MM; Schapiro JM; Schmidt D; Seu L; Sigaloff KCE; Sirivichayakul S; Skhosana L; Sunpath H; Tang M; Yang C; Carmona S; Gupta RK; Shafer RW, 2017, 'Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration', EBioMedicine, 18, pp. 225 - 235, http://dx.doi.org/10.1016/j.ebiom.2017.03.024
2017
Wright E; Grulich A; Roy K; Boyd M; Cornelisse V; Russell D; O'Donnell D; Whittaker B; Crooks L; Zablotska I, 2017, 'Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine HIV pre-exposure prophylaxis: clinical guidelines', Journal of Virus Eradication, 3, pp. 168 - 184, http://dx.doi.org/10.1016/s2055-6640(20)30338-1
2017
Thit SS; Aung NM; Htet ZW; Boyd MA; Saw HA; Anstey NM; Kyi TT; Cooper DA; Kyi MM; Hanson JP, 2017, 'The clinical utility of the urine-based lateral flow lipoarabinomannan assay in HIV-infected adults in Myanmar: an observational study.', BMC Medicine, 15, pp. 145, http://dx.doi.org/10.1186/s12916-017-0888-3
2017
Boyd MA; Mocroft A; Ryom L; Monforte AD; Sabin C; El-Sadr WM; Hatleberg CI; De Wit S; Weber R; Fontas E; Phillips A; Bonnet F; Reiss P; Lundgren J; Law M; Han A, 2017, 'Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study', PLoS Medicine, 14, pp. e1002424, http://dx.doi.org/10.1371/journal.pmed.1002424
2017
Bell SK; Mena G; Dean J; Boyd M; Gilks C; Gartner C, 2017, 'Vaporised nicotine and tobacco harm reduction for addressing smoking among people living with HIV: A cross-sectional survey of Australian HIV health practitioners’ attitudes', Drug and Alcohol Dependence, 177, pp. 67 - 70, http://dx.doi.org/10.1016/j.drugalcdep.2017.03.023
2017
Boyd MA; Cooper DA, 2017, 'Long-acting injectable ART: next revolution in HIV?', The Lancet, 390, pp. 1468 - 1470, http://dx.doi.org/10.1016/S0140-6736(17)31962-1
2017
Boyd MA, 2017, 'Body composition substudy of the SECOND-LINE study – Author's reply', The Lancet HIV, 4, pp. e240, http://dx.doi.org/10.1016/S2352-3018(17)30093-0
2017
Alvarez E; Belloso WH; Boyd MA; Inkaya AC; Hsieh E; Kambugu A; Kaminski G; Martinez E; Stellbrink HJ; Walmsley S; Brown TT; Mallon PWG, 2016, 'Which HIV patients should be screened for osteoporosis: An international perspective', Current Opinion in HIV and AIDS, 11, pp. 268 - 276, http://dx.doi.org/10.1097/COH.0000000000000269
2016
Achhra AC; Mwasakifwa G; Amin J; Boyd MA, 2016, 'Efficacy and safety of contemporary dual-drug antiretroviral regimens as first-line treatment or as a simplification strategy: a systematic review and meta-analysis', The Lancet HIV, 3, pp. e351 - e360, http://dx.doi.org/10.1016/S2352-3018(16)30015-7
2016
Zaunders J; Danta M; Bailey M; Mak G; Marks K; Seddiki N; Xu Y; Templeton DJ; Cooper DA; Boyd MA; Kelleher AD; Koelsch KK, 2016, 'CD4+ T follicular helper and IgA+ B cell numbers in gut biopsies from HIV-infected subjects on antiretroviral therapy are similar to HIV-uninfected individuals', Frontiers in Immunology, 7, pp. 438, http://dx.doi.org/10.3389/fimmu.2016.00438
2016
Lambert-Niclot S; George EC; Pozniak A; White E; Schwimmer C; Jessen H; Johnson M; Dunn D; Perno CF; Clotet B; Plettenberg A; Blaxhult A; Palmisano L; Wittkop L; Calvez V; Marcelin AG; Raffi F; Dedes N; Chěne G; Allavena C; Autran B; Antinori A; Bucciardini R; Vella S; Horban A; Arribas J; Babiker AG; Boffito M; Pillay D; Pozniak A; Franquet X; Schwarze S; Grarup J; Fischer A; Richert L; Wallet C; Diallo A; Molina JM; Saillard J; Moecklinghoff C; Stellbrink HJ; Van Leeuwen R; Gatell J; Sandstrom E; Flepp M; Ewings F; George EC; Hudson F; Pearce G; Quercia R; Rogatto F; Leavitt R; Nguyen BY; Goebel F; Marcotullio S; Kaur N; Sasieni P; Spencer-Drake C; Peto T; Miller V; Arnault F; Boucherie C; Jean D; Paniego V; Paraina F; Rouch E; Soussi M; Taieb A; Termote M; Touzeau G; Cursley A; Dodds W; Hoppe A; Kummeling I; Pacciarini F; Paton N; Russell C; Taylor K; Ward D; Aagaard B; Eid M; Gey D; Jensen BG; Jakobsen ML; Jansson PO; Jensen K; Joensen ZM; Larsen EM; Pahl C; Pearson M; Nielsen BR; Reilev SS; Christ I; Lathouwers D; Manting C; Mendy BY; Metro A; Couffin-Cadiergues S; Knellwolf AL, 2016, 'Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: Raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART', Journal of Antimicrobial Chemotherapy, 71, pp. 1056 - 1062, http://dx.doi.org/10.1093/jac/dkv427
2016
Lam EP; Moore CL; Gotuzzo E; Nwizu C; Kamarulzaman A; Chetchotisakd P; Van Wyk J; Teppler H; Kumarasamy N; Molina JM; Emery S; Cooper DA; Boyd MA, 2016, 'Antiretroviral resistance after first-line antiretroviral therapy failure in diverse HIV-1 subtypes in the SECOND-LINE study', AIDS Research and Human Retroviruses, 32, pp. 841 - 850, http://dx.doi.org/10.1089/aid.2015.0331
2016
Boyd M; Cooper D; Crock EA; Crooks L; Giles ML; Grulich A; Lewin SR; Nolan D; Yarwood T, 2016, 'Sexual transmission of HIV and the law: An Australian medical consensus statement', Medical Journal of Australia, 205, pp. 409 - 412, http://dx.doi.org/10.5694/mja16.00934
2016
Boyd MA; Cooper DA, 2016, 'Tenofovir alafenamide: safer, but questions remain', The Lancet HIV, 3, pp. e148 - e149, http://dx.doi.org/10.1016/S2352-3018(16)00039-4
2016
Boyd MA; Cooper DA, 2016, 'Novel antiretroviral agents and universal access to HIV care', The Lancet HIV, 3, pp. e2 - e3, http://dx.doi.org/10.1016/S2352-3018(15)00244-1
2016
Arts E; Boyd M, 2016, 'Reviewer acknowledgement.', AIDS Res Ther, 13, pp. 13, http://dx.doi.org/10.1186/s12981-016-0097-8
2016
Arts E; Boyd M, 2016, 'Reviewer acknowledgement.', AIDS Res Ther, 13, pp. 13, http://dx.doi.org/10.1186/s12981-016-0097-8
2016
Cummins NW; Neuhaus J; Chu H; Neaton J; Wyen C; Rockstroh JK; Skiest DJ; Boyd MA; Khoo S; Rotger M; Telenti A; Weinshilboum R; Badley AD, 2015, 'Investigation of Efavirenz Discontinuation in Multi-ethnic Populations of HIV-positive Individuals by Genetic Analysis', EBioMedicine, 2, pp. 706 - 712, http://dx.doi.org/10.1016/j.ebiom.2015.05.012
2015
Han N; Wright ST; O'Connor CC; Hoy J; Ponnampalavanar S; Grotowski M; Zhao HX; Kamarulzaman A; Ellis D; Bloch M; Franic T; Agrawal S; McCann L; Cunningham N; Vincent T; Allen D; Little JL; Smith D; Gray C; Baker D; Vale R; Templeton DJ; Dijanosic C; Jackson E; McCallum K; Taylor S; Cooper D; Carr A; Lee F; Hesse K; Sinn K; Norris R; Finlayson R; Prone I; Shakeshaft J; Brown K; McGrath C; McGrath V; Halligan S; Wray L; Read P; Lu H; Couldwell D; Furner V; Watson J; Lawrence C; Mulhall B; Law M; Petoumenos K; McManus H; Bendall C; Boyd M; Kulatunga A; Knibbs P; Chuah J; Ngieng M; Dickson B; Russell D; Downing S; Sowden D; Broom J; Taing K; Johnston C; McGill K; Orth D; Youds D; Kelly M; Gibson A; Magon H; Donohue W; Moore R; Edwards S; Liddle R; Locke P; Roth NJ; Nicolson J; Lau H; Read T; Silvers J; Zeng W; Watson K; Bryant M; Price S; Woolley I; Giles M; Korman T; Williams J; Nolan D; Skett J; Robinson J; Mean CV; Saphonn V; Vohith K; Zhang FJ; Li PCK; Lee MP; Kumarasamy N; Saghayam S; Ezhilarasi C; Pujari S, 2015, 'HIV and aging: Insights from the Asia Pacific HIV Observational Database (APHOD)', HIV Medicine, 16, pp. 152 - 160, http://dx.doi.org/10.1111/hiv.12188
2015
Templeton DJ; Wright ST; McManus H; Lawrence C; Russell DB; Law MG; Petoumenos K; Ellis D; Bloch M; Agrawal S; Vincent T; Allen D; Smith D; Allardice K; Baker D; Odgers E; O'Connor CC; Phan S; Jackson E; McCallum K; Grotowski M; Ryder N; Taylor S; Cooper D; Carr A; Lee F; McRae K; Hesse K; Finlayson R; Gupta S; Varma R; Shakeshaft J; Brown K; McGrath V; Halligan S; Arvela N; Wray L; Thng C; Foster R; Lu H; Couldwell D; DSmith E; Furner V; Fernando S; Dubbo ; Watson J; Mulhall B; Wright S; Bendall C; Boyd M; Gunathilake M; Payne R; O'Sullivan M; White S; Russell D; Joslin J; Cashman C; Sowden D; Taing K; McGill K; Orth D; Youds D; Kelly M; Rowling D; Latch N; Warzywoda E; Dickson B; Donohue W; Moore R; Edwards S; Boyd S; NRoth J; Lau H; Read T; Silvers J; Zeng W; Hoy J; Watson K; Bryant M; Price S; Woolley I; Giles M; Korman T; Williams J; Nolan D; Guelfi G; Mills G; Wharry C; Raymond N; Bargh K; Morwood K; Roth N; Choong K; Cooper D; Han A, 2015, 'Antiretroviral treatment use, co-morbidities and clinical outcomes among Aboriginal participants in the Australian HIV Observational Database (AHOD)', BMC Infectious Diseases, 15, pp. 326, http://dx.doi.org/10.1186/s12879-015-1051-4
2015
Amin J; Boyd MA; Kumarasamy N; Moore CL; Losso MH; Nwizu CA; Mohapi L; Kerr SJ; Sohn AH; Teppler H; Renjifo B; Molina JM; Emery S; Cooper DA, 2015, 'Erratum: Raltegravir Non-Inferior to Nucleoside Based Regimens in SECOND-LINE Therapy with Lopinavir/Ritonavir over 96 Weeks: A Randomised Open Label Study for the Treatment Of HIV-1 Infection (PLoS ONE (2015)10:2 (e0118228) Doi: 10.1371/journal.pone.0118228 ))', PLoS ONE, 10, pp. e0140623, http://dx.doi.org/10.1371/journal.pone.0140623
2015
Amin J; Becker S; Belloso W; Boffito M; Cooper D; Crabtree-Ramirez B; Duncombe C; Foulkes S; Hill A; Jessen H; Kumar S; Lee MP; Nwizu C; Read T; Rooney J; Schaffer K; Shahar E; Winston A; Wolff M; Young B; Abela C; Avihingsanon A; Boyd M; Carey D; Clarke A; Courtney-Vega K; Delfino M; Donaldson A; Emery S; Espinosa N; Johannesen T; Lin E; Losso M; Moricz A; Pett S; Phanupak P; Puls R; Pussadee K; Sutheerasak P; Tomlins L; Ubolyam S; bin Raja Azwa RIS; Bissio E; Calanni L; Chetchotisakd P; Doong N; Elliott J; Gazzard B; Kelly M; Laplume H; del Carmen Luna N; Lupo S; Messina OG; Mohapi L; Moore R; Nolan D; Orrell C; Perez C; Phanuphak P; Rockstroh J; Rowling D; Supparatpinyo K; Smith D; Villanueva JA; Vlahakis E; Kelleher T; Cunningham P; Merlin K; Yeung J; Shaik A; Fsadni B; Carrera A; Lograsso M; Gulick R; Dunn D; Dolan M; Emery S; Kelleher A, 2015, 'Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study', The Lancet Infectious Diseases, 15, pp. 793 - 802, http://dx.doi.org/10.1016/S1473-3099(15)70060-5
2015
Boyd MA; Donovan B; Prestage G; Chen M; Petoumenos K; Gray R; Guy R; Rogers GB; Bourne C; Klausner JD, 2015, 'Is it time to rethink syphilis control?', Clinical Infectious Diseases, 60, pp. 325 - 326, http://dx.doi.org/10.1093/cid/ciu813
2015
Boyd MA; Moore CL; Molina JM; Wood R; Madero JS; Wolff M; Ruxrungtham K; Losso M; Renjifo B; Teppler H; Kelleher AD; Amin J; Emery S; Cooper DA, 2015, 'Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: An exploratory analysis', The Lancet HIV, 2, pp. e42 - e51, http://dx.doi.org/10.1016/S2352-3018(14)00061-7
2015
Amin J; Boyd MA; Kumarasamy N; Moore CL; Losso MH; Nwizu CA; Mohapi L; Kerr SJ; Sohn AH; Teppler H; Renjifo B; Molina JM; Emery S; Cooper DA, 2015, 'Raltegravir non-inferior to nucleoside based regimens in second-line therapy with lopinavir/ritonavir over 96 weeks: A randomised open label study for the treatment of HIV-1 infection', PLoS ONE, 10, pp. e0118228, http://dx.doi.org/10.1371/journal.pone.0118228
2015
McManus H; Hoy JF; Woolley I; Boyd MA; Kelly MD; Mulhall B; Roth NJ; Petoumenos K; Law MG, 2015, 'Erratum: Recent trends in early stage response to combination antiretroviral therapy in Australia', Antiviral Therapy, 20, pp. 255, http://dx.doi.org/10.3851/IMP2822
2015
McManus H; Hoy JF; Woolley I; Boyd MA; Kelly MD; Mulhall B; Roth NJ; Petoumenos K; Law MG; Han A, 2015, 'Recent trends in early stage response to combination antiretroviral therapy in Australia', Antiviral Therapy, 20, pp. 131 - 139, http://dx.doi.org/10.3851/IMP2774
2015
Boyd MA; Cooper DA, 2015, 'The LATTE study: A provocative brew', The Lancet Infectious Diseases, 15, pp. 1116 - 1117, http://dx.doi.org/10.1016/S1473-3099(15)00224-8
2015
Raffi F; Babiker AG; Richert L; Molina JM; George EC; Antinori A; Arribas JR; Grarup J; Hudson F; Schwimmer C; Saillard J; Wallet C; Jansson PO; Allavena C; Van Leeuwen R; Delfraissy JF; Vella S; Chêne G; Pozniak A, 2014, 'Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial', The Lancet, 384, pp. 1942 - 1951, http://dx.doi.org/10.1016/S0140-6736(14)61170-3
2014
Haskelberg H; Mallon PWG; Hoy J; Amin J; Moore C; Phanuphak P; Ferret S; Belloso WH; Boyd MA; Cooper DA; Emery S, 2014, 'Bone mineral density over 96 weeks in adults failing first-line therapy randomized to raltegravir/lopinavir/ ritonavir compared with standard second-line therapy', Journal of Acquired Immune Deficiency Syndromes, 67, pp. 161 - 168, http://dx.doi.org/10.1097/QAI.0000000000000288
2014
Holt SG; Gracey DM; Levy MT; Mudge DW; Irish AB; Walker RG; Baer R; Sevastos J; Abbas R; Boyd MA, 2014, 'A consensus statement on the renal monitoring of Australian patients receiving tenofovir based antiviral therapy for HIV/HBV infection', AIDS Research and Therapy, 11, http://dx.doi.org/10.1186/1742-6405-11-35
2014
Haskelberg H; Pocock N; Amin J; Ebeling PR; Emery S; Carr A; Post J; Medland N; Boyd M, 2014, 'Hip structural parameters over 96 weeks in HIV-infected adults switching treatment to tenofovir-emtricitabine or abacavir-lamivudine', PLoS ONE, 9, pp. e94858, http://dx.doi.org/10.1371/journal.pone.0094858
2014
Wright ST; Hoy J; Mulhall B; OʼConnor CC; Petoumenos K; Read T; Smith D; Woolley I; Boyd MA; O'Connor C, 2014, 'Determinants of Viremia Copy-Years in People With HIV/AIDS After Initiation of Antiretroviral Therapy', JAIDS Journal of Acquired Immune Deficiency Syndromes, 66, pp. 55 - 64, http://dx.doi.org/10.1097/qai.0000000000000125
2014
Achhra AC; Boyd MA; Law MG; Matthews GV; Kelleher AD; Cooper DA; Han A, 2014, 'Moving away from ritonavir, abacavir, tenofovir, and efavirenz (RATE) - Agents that concern prescribers and patients: A feasibility study and call for a trial', PLoS ONE, 9, pp. e99530, http://dx.doi.org/10.1371/journal.pone.0099530
2014
Revell AD; Boyd MA; Wang D; Emery S; Gazzard B; Reiss P; van Sighem A; Montaner JS; Lane HC; Larder BA, 2014, 'A comparison of computational models with and without genotyping for prediction of response to second-line HIV therapy', HIV Medicine, 15, pp. 442 - 448, http://dx.doi.org/10.1111/hiv.12156
2014
Haskelberg H; Mallon PWG; Hoy J; Amin J; Moore C; Phanuphak P; Ferret S; Belloso WH; Boyd MA; Cooper DA; Emery S; Cooper D, 2014, 'Bone mineral density over 96 weeks in adults failing first-line therapy randomised to raltegravir/lopinavir/ritonavir compared to standard second-line therapy', Journal of Acquired Immune Deficiency Syndromes, http://dx.doi.org/10.1097/QAI.0000000000000288
2014
Achhra AC; Boyd MA, 2013, 'Antiretroviral regimens sparing agents from the nucleoside(tide) reverse transcriptase inhibitor class: A review of the recent literature', AIDS Research and Therapy, 10, http://dx.doi.org/10.1186/1742-6405-10-33
2013
Suzuki K; Hattori S; Marks K; Ahlenstiel C; Maeda Y; Ishida T; Millington M; Boyd M; Symonds G; Cooper DA; Okada S; Kelleher AD, 2013, 'Promoter Targeting shRNA Suppresses HIV-1 Infection In vivo Through Transcriptional Gene Silencing', Molecular Therapy Nucleic Acids, 2, pp. e137, http://dx.doi.org/10.1038/mtna.2013.64
2013
Martin A; Moore C; Mallon PWG; Hoy J; Emery S; Belloso W; Phanuphak P; Ferret S; Cooper DA; Boyd MA, 2013, 'Bone mineral density in HIV participants randomized to raltegravir and lopinavir/ritonavir compared with standard second line therapy', AIDS, 27, pp. 2403 - 2411, http://dx.doi.org/10.1097/01.aids.0000432534.47217.b4
2013
Schneider K; Nwizu CA; Kaplan R; Anderson JS; Wilson DP; Emery S; Cooper DA; Boyd MA, 2013, 'The Potential Cost and Benefits of Raltegravir in Simplified Second-Line Therapy among HIV Infected Patients in Nigeria and South Africa', PLoS ONE, 8, pp. e54435, http://dx.doi.org/10.1371/journal.pone.0054435
2013
Wright S; Boyd MA; Yunihastuti E; Law M; Sirisanthana T; Hoy J; Pujari S; Lee MP; Petoumenos K; Templeton D; Han A, 2013, 'Rates and Factors Associated with Major Modifications to First-Line Combination Antiretroviral Therapy: Results from the Asia-Pacific Region', PLoS ONE, 8, pp. e64902, http://dx.doi.org/10.1371/journal.pone.0064902
2013
Wright ST; Petoumenos K; Boyd MA; Carr AD; Downing S; O''connor C; Grotowski M; Law MG, 2013, 'Ageing and long-term CD4 cell count trends in HIV-positive patients with 5 years or more combination antiretroviral therapy experience', HIV Medicine, 14, pp. 208 - 216, http://dx.doi.org/10.1111/j.1468-1293.2012.01053.x
2013
Jansson J; Wilson DP; Carr A; Petoumenos K; Boyd MA, 2013, 'Currently available medications in resource-rich settings may not be sufficient for lifelong treatment of HIV', AIDS, 27, pp. 1245 - 1251, http://dx.doi.org/10.1097/QAD.0b013e32835e163d
2013
Boyd MA, 2013, 'Ritonavir-boosted lopinavir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in adults with virological failure of a standard first-line ART regimen (SECOND-LINE): A randomised, open-label, non-inferiority study', Lancet, 381, pp. 2091 - 2099, http://dx.doi.org/10.1016/S0140-6736(13)61164-2
2013
Martin A; Moore CL; Mallon PWG; Hoy JF; Emery S; Belloso WH; Phanuphak P; Ferret S; Cooper DA; Boyd MA; Second-Line Study Team , 2013, 'HIV lipodystrophy in participants randomised to lopinavir/ritonavir (LPV/r) +2-3 nucleoside/nucleotide reverse transcriptase inhibitors (N(t)RTI) or LPV/r + raltegravir as second-line antiretroviral therapy.', PloS one, 8, http://dx.doi.org/10.1371/journal.pone.0077138
2013
Boyd MA; Cooper DA, 2013, 'SPRING-2 the future of antiretroviral therapy', The Lancet Infectious Diseases, 13, pp. 908 - 909, http://dx.doi.org/10.1016/S1473-3099(13)70194-4
2013
Byakwaga H; Petoumenos K; Ananworanich J; Zhang F; Boyd MA; Sirisanthana T; Li PCK; Lee C; Mean CV; Saphonn V; Omar SFS; Pujari S; Phanuphak P; Lim PL; Kumarasamy N; Chen YMA; Merati TP; Sungkanuparph S; Ditangco R; Oka S; Tau G; Zhou J; Law MG; Emery S; Han A, 2013, 'Predictors of clinical progression in HIV-1-infected adults initiating combination antiretroviral therapy with advanced disease in the Asia-Pacific region: Results from the TREAT Asia HIV Observational Database', Journal of the International Association of Providers of AIDS Care, 12, pp. 270 - 277, http://dx.doi.org/10.1177/1545109712469684
2013
Boyd MA; Donovan B, 2013, 'Antiretroviral therapy: Dolutegravir sets SAIL(ING)', The Lancet, 382, pp. 664 - 666, http://dx.doi.org/10.1016/S0140-6736(13)61456-7
2013
McManus H; O'Connor CC; Boyd MA; Broom J; Russell D; Watson K; Roth N; Read PJ; Law M; Petoumenos K; Templeton D; Han A, 2012, 'Long-term survival in HIV positive patients with up to 15 years of antiretroviral therapy', PLoS One, 7, pp. Article numbere48839, http://dx.doi.org/10.1371/journal.pone.0048839
2012
Haskelberg H; Hoy J; Amin J; Ebeling PR; Emery S; Carr AD, 2012, 'Changes in Bone Turnover and Bone Loss in HIV-Infected Patients Changing Treatment to Tenofovir-Emtricitabine or Abacavir-Lamivudine', PLoS ONE, 7, pp. e38377, http://dx.doi.org/10.1371/journal.pone.0038377
2012
Carey DL; Pett SL; Bloch M; Wand H; MacRae K; Beileiter K; Ray J; Boyd MA; Emery S; Cooper DA, 2012, 'A randomized study of pharmacokinetics, efficacy, and safety of 2 raltegravir plus atazanavir strategies in ART-treated adults', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 60, pp. 143 - 149, http://dx.doi.org/10.1097/QAI.0b013e318252f97e
2012
Avihingsanon A; van der Lugt J; Singphore U; Gorowara M; Boyd MA; Ananworanich J; Phanuphak P; Burger DM; Ruxrungtham K, 2012, 'Pharmacokinetics and 48 week efficacy of adjusted dose indinavir/ritonavir in rifampicin-treated HIV/tuberculosis-coinfected patients: A pilot study', AIDS Research and Human Retroviruses, 28, pp. 1170 - 1176, http://dx.doi.org/10.1089/aid.2011.0247
2012
Jansson J; Wilson D; Carr A; Petoumenos K; Boyd M, 2012, 'Currently available medications may not be sufficient for lifelong treatment of HIV', JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 15, pp. 4 - 4, http://dx.doi.org/10.7448/IAS.15.6.18077
2012
Boyd MA; Cooper DA, 2012, 'Optimisation of HIV care and service delivery: doing more with less', Lancet, 380, pp. 1860 - 1866, http://dx.doi.org/10.1016/S0140-6736(12)61154-4
2012
Boyd MA, 2012, 'Dolutegravir — a promising antiretroviral in development', Lancet Infectious Diseases, 12, pp. 90 - 91, http://dx.doi.org/10.1016/S1473-3099(11)70291-2
2012
Boyd MA; Mohapi L, 2012, 'STRETCHing delivery of HIV health services', Lancet, 380, pp. 865 - 867, http://dx.doi.org/10.1016/S0140-6736(12)60952-0
2012
Revell ; Wang ; Boyd MA; Emery S; Pozniak A; de WF; Harrigan R; Montaner JSG; Lane C; Larder B, 2011, 'The development of an expert system to predict virological response to HIV therapy as part of an online treatment support tool', AIDS, 25, pp. 1855 - 1863, http://dx.doi.org/10.1097/QAD.0b013e328349a9c2
2011
Byakwaga H; Purcell DJ; French MA; Amin J; Lewin S; Haskelberg H; Kelleher AD; Garsia RJ; Boyd MA; Cooper DA; Emery S, 2011, 'Intensification of antiretroviral therapy with raltegravir or addition of hyperimmune bovine colostrum in HIV-infected patients with suboptimal CD4 + T-cell response: A randomized controlled trial', Journal of Infectious Diseases, 204, pp. 1532 - 1540, http://jid.oxfordjournals.org/content/204/10/1532
2011
Wilson DP; Grulich AE; Boyd MA, 2011, 'Overly optimistic forecasts of the impact of treatment as HIV prevention for men who have sex with men', Clinical Infectious Diseases, 53, pp. 611 - 612
2011
Carey DL; Amin J; Boyd MA; Petoumenos K; Emery S, 2010, 'Lipid profiles in HIV-infected adults receiving atazanavir and atazanavir/ritonavir: systematic review and meta-analysis of randomised controlled trials', Journal of Antimicrobial Chemotherapy, 65, pp. 1878 - 1888
2010
Zhou J; Li PCK; Kumarasamy N; Boyd MA; Chen YMA; Sirisanthana T; Sungkanuparph S; Oka S; Tau G; Phanuphak P; Saphonn V; Zhang FJ; Omar SFS; Lee CKC; Ditangco R; Merati TP; Lim PL; Choi JY; Law MG; Pujari S, 2010, 'Deferred modification of antiretroviral regimen following documented treatment failure in Asia: results from the TREAT Asia HIV Observational Database (TAHOD)', HIV Medicine, 11, pp. 31 - 39
2010
Boyd MA, 2010, 'Current and future management of treatment failure in low- and middle-income countries', Current opinion in HIV & AIDS, 5, pp. 83 - 89
2010
Boyd MA; Hill A, 2010, 'Clinical management of treatment-experienced, HIV/AIDS patients in the combination antiretroviral therapy era', Pharmacoeconomics, 28, pp. 17 - 34
2010
Boyd MA; Hill AM, 2010, 'Clinical management of treatment-experienced, HIV/AIDS patients in the combination antiretroviral therapy era', PharmacoEconomics, 28, pp. 17 - 34, http://dx.doi.org/10.2165/11587420-000000000-00000
2010
Boyd MA; Nwizu CA, 2010, 'Operational research in HIV priority areas: the African way', The Lancet, 376, pp. 4 - 6, http://dx.doi.org/10.1016/S0140-6736(10)60972-5
2010
Byakwaga H; Murray JM; Petoumenos K; Kelleher AD; Law MG; Boyd MA; Emery S; Mallon PW; Cooper DA, 2009, 'Evolution of CD4+T cell count in HIV-1-infected adults receiving antiretroviral therapy with sustained long-term virological suppression', AIDS Research and Human Retroviruses, 25, pp. 569 - 576
2009
Byakwaga H; Zhou J; Petoumenos K; Law MG; Boyd MA; Emery S; Cooper DA; Mallon PW, 2009, 'Effect of nucleoside reverse transcriptase inhibitors on CD4 T-cell recovery in HIV-1-infected individuals receiving long-term fully suppressive combination antiretroviral therapy', HIV Medicine, 10, pp. 143 - 151
2009
Boyd MA, 2009, 'Improvements in antiretroviral therapy outcomes over calendar time', Current Opinion in HIV and AIDS, 4, pp. 194 - 199, http://dx.doi.org/10.1097/COH.0b013e328329fc8d
2009
Mcintyre GJ; Yu Y; Tran A; Jaramillo AB; Arndt AJ; Millington ML; Boyd MP; Elliott FA; Shen SW; Murray JM; Applegate TL, 2009, 'Cassette deletion in multiple shRNA lentiviral vectors for HIV-1 and its impact on treatment success', Virology Journal, 6, pp. 184, http://www.virologyj.com/content/6/1/184
2009
Boyd M, 2009, 'Clinical research in low- And middle-income countries', Virtual Mentor, 11, pp. 511 - 515, http://dx.doi.org/10.1001/virtualmentor.2009.11.7.jdsc1-0907
2009
Boyd MA; Emery S; Cooper DA, 2009, 'Antiretroviral roll-out: the problem of second-line therapy', Lancet, 374, pp. 185 - 186
2009
Boyd MA, 2009, 'Improvements in antiretroviral therapy outcomes over calendar time', Current opinion in HIV & AIDS, 4, pp. 194 - 199, http://dx.doi.org/10.1097/COH.013e328329fc8d
2009
Boyd MA; Truman M; Holes G; Anderson JA; Dwyer DE; Carr AD, 2008, 'A randomized study to evaluate injection site reactions using three different enfuvirtide delivery mechanisms (the OPTIONS study)', Antiviral Therapy, 13, pp. 449 - 453
2008
Boyd MA; Pett SL, 2008, 'Experimental and clinical pharmacology - HIV fusion inhibitors: a review', Australian Prescriber, 31, pp. 66 - 69
2008
Colebunders R; French M; Oelrichs R; Boyd M, 2008, 'Editorial introductions', Current Opinion in HIV and AIDS, 3, http://dx.doi.org/10.1097/COH.0b013e32830890a4
2008
Boyd MA; Byakwaga H, 2008, 'Considering the benefits of disease-specific interventions on overall public health', Lancet Infectious Diseases, 8, pp. 278 - 278
2008
Oelrichs R; Boyd M, 2008, 'Evidence and policy in the globalized response to AIDS', Current Opinion in HIV and AIDS, 3, pp. 477 - 480, http://dx.doi.org/10.1097/COH.0b013e328303ba0b
2008
Boyd MA, 2007, 'Indinavir: the forgotten HIV-protease inhibitor. Does it still have a role?', Expert Opinion on Pharmacotherapy, 8, pp. 957 - 964
2007
Boyd MA; Cooper DA, 2007, 'Second-line combination antiretroviral therapy in resource-limited settings: facing the challenges through clinical research', AIDS, 21, pp. S55 - S63
2007
Boyd MA; Truman M; Hales GP; Anderson JS; Dwyer DE; Carr AD, 2007, 'A randomized study to evaluate injection site reactions (ISR) using three different mechanisms for delivery of enfuvirtide (ENF): a 27-gauge needle, a 31-gauge needle and a needle-free device', Antiviral Therapy, 12, pp. L57 - L57, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000249773400105&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2007
Autar R; Boyd MA; Wit F; Ruxrungtham K; Sankote J; Lange JM; Cooper DA; Phanuphak P; Burger DM; Reiss P, 2007, 'Relationships between drug exposure, changes in metabolic parameters and body fat in HIV-infected patients switched to a nucleoside sparing regimen', Antiviral Therapy, 12, pp. 1265 - 1271
2007
Snelling T; Ossowicz C; Boyd M, 2007, 'Case report: Co-infections in an HIV-infected man from Malawi', American Journal of Tropical Medicine and Hygiene, 76, pp. 180 - 181, http://dx.doi.org/10.4269/ajtmh.2007.76.180
2007
Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG, 2007, 'Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment', HIV Medicine, 8, pp. 46 - 54
2007
Kerr SJ; Duncombe CJ; Avihingsanon A; Ananworanich J; Boyd MA; Sopa B; Chuenyam T; Cooper DA; Lange JM; Phanuphak P; Ruxrungtham K, 2007, 'Dyslipidemia in an Asian population after treatment for two years with protease inhibitor-containing regimens.', Journal of the International Association of Physicians in AIDS Care, 6, pp. 36 - 46
2007
Boyd MA; Hedger S, 2007, 'An unusual cause of severe metabolic acidosis [5]', Medical Journal of Australia, 186, pp. 158, http://dx.doi.org/10.5694/j.1326-5377.2007.tb00846.x
2007
Boyd MA; Menon P; Graves S; Gordon DL, 2007, 'A febrile illness with generalized papular rash involving the palms and soles', Clinical Infectious Diseases, 44, http://dx.doi.org/10.1086/511637
2007
Cooper DA; Cahn PE; Lewin S; Kaldor JM; McClure C; Kort R; Boyd MA, 2007, 'The Sydney Declaration: a call to scale up research', Lancet, 370, pp. 7 - 8
2007
Mackowiak PA; Boyd MA; Menon P; Graves S; Gordon DL, 2007, 'A Febrile Illness with Generalized Papular Rash Involving the Palms and Soles', Clinical Infectious Diseases, 44, pp. 755 - 756, http://dx.doi.org/10.1086/511651
2007
Kong A; Koukourou A; Boyd M; Crowe G, 2006, 'Metastatic adenocarcinoma mimicking 'target sign' of cerebral tuberculosis', Journal of Clinical Neuroscience, 13, pp. 955 - 958, http://dx.doi.org/10.1016/j.jocn.2005.11.039
2006
Boyd M; Clezy K; Lindley R; Pearce R, 2006, 'Pandemic influenza: Clinical issues', Medical Journal of Australia, 185, http://dx.doi.org/10.5694/j.1326-5377.2006.tb00706.x
2006
Boyd MA; Carr AD; Ruxrungtham K; Srasuebkul P; Bien D; Law MG; Wangsuphachart S; Krisanachinda A; Lerdlum S; Lange J; Phanuphak P; Cooper DA; Reiss P, 2006, 'Changes in body composition and mitochondrial nucleic acid content in patients switched from failed nucleoside analogue therapy to Ritonavir-boosted Indinavir and Efavirenz', Journal of Infectious Diseases, 194, pp. 642 - 650
2006
Boyd MA; Srasuebkul P; Ruxrungtham K; Mackenzie P; Uchaipichat V; Stek M; Lange JM; Phanuphak P; Cooper DA; Udomuksorn W; Miners JO, 2006, 'Relationship between hyperbilirubinaemia and UDP-glucuronosyltransferase 1A1 (UGT1A1) polymorphism in adult HIV-infected Thai patients treated with indinavir', Pharmacogenetics and Genomics, 16, pp. 321 - 329
2006
Boyd MA; Dixit N; Siangphoe U; Buss N; Salgo M; Lange J; Phanuphak P; Cooper DA; Perelson A; Ruxrungtham K, 2006, 'Viral decay dynamics in HIV-infected patients receiving ritonavir-boosted saquinavir and efavirenz with or without enfuvirtide: A randomized, controlled trial (HIV-NAT 012)', Journal of Infectious Diseases, 194, pp. 1319 - 1322
2006
Boyd MA; Srasuebkul P; Khongphattanayothin M; Ruxrungtham K; Hassink EA; Duncombe CJ; Ubolyam S; Burger DM; Reiss P; Stek M; Lange JM; Cooper DA; Phanuphak P, 2006, 'Boosted versus unboosted indinavir with zidovudine and lamivudine in nucleoside pre-treated patients: a randomized, open-label trial with 112 weeks of follow-up (HIV-NAT 005).', Antiviral Therapy, 11, pp. 223 - 232
2006
Boyd M; Reiss P, 2006, 'The long-term consequences of antiretroviral therapy: A review', Journal of HIV Therapy, 11, pp. 26 - 35
2006
Boyd MA; Siangphoe U; Ruxrungtham K; Reiss P; Mahanontharit A; Lange JM; Phanuphak P; Cooper DA; Burger D, 2006, 'The use of pharmacokinetically guided indinavir dose reductions in the management of indinavir-associated renal toxicity', Journal of Antimicrobial Chemotherapy, 57, pp. 1161 - 1167
2006
Boyd M; Rogers W, 2006, 'Industry and bioethics: What price the relationship? [3]', PLoS Medicine, 3, pp. 0933, http://dx.doi.org/10.1371/journal.pmed.0030281
2006
Boyd MA; Burger D; Phanuphak P; Cooper DA, 2006, 'Maintenance of successful ritonavir-boosted indinavir and efavirenz therapy in an HIV-infected patient with tuberculosis', AIDS, 20, pp. 1083 - 1085
2006
Boyd M; Reiss P, 2006, 'Erratum: The long-term effects of antiretroviral therapy: A review (Journal of HIV Therapy 11, 2 (28))', Journal of HIV Therapy, 11
2006
Macpherson JL; Boyd MP; Arndt AJ; Todd AV; Ganning GC; Ely JA; Elliott F; Knop A; Raponi M; Murray JM; Gerlach W; Sun L; Penny R; Symonds GP; Carr AD; Cooper DA, 2005, 'Long-term survival and concomitant gene expression of ribozyme-transduced CD4+ T-lymphocytes in HIV-infected patients', Journal of Gene Medicine, 7, pp. 552 - 564
2005
Boyd MA; Mootsikapun P; Burger D; Chuenyam T; Ubolyam S; Mahanontharit A; Sangkote J; Bunyaprawit P; Horsakulchai M; Lange JM; Cooper DA; Phanuphak P; Ruxrungtham K, 2005, 'Pharmacokinetics of reduced-dose indinavir/ritonavir 400/100 mg twice daily in HIV-1-infected Thai patients', Antiviral Therapy, 10, pp. 301 - 307
2005
Boyd MA; Siangphoe U; Ruxrungtham K; Duncombe CJ; Stek M; Lange JM; Cooper DA; Phanuphak P, 2005, 'Indinavir/ritonavir 800/100mg bid and efavirenz 600mg qd in patients failing treatment with combination nucleoside reverse transcriptase inhibitors: 96-week outcomes of HIV-NAT 009', HIV Medicine, 6, pp. 410 - 420
2005
Ruxrungtham K; Boyd MA; Bellibas S; Zhang X; Dorr A; Kolis S; Kinchelow T; Buss N; Patel IH, 2004, 'Lack of interaction between enfuvirtide and ritonavir or ritonavir-boosted saquinavir in HIV-1-infected patients', Journal of Clinical Pharmacology, 44, pp. 793 - 802
2004
Law WP; Duncombe CJ; Mahanontharit A; Boyd MA; Ruxrungtham K; Lange JM; Phanuphak P; Cooper DA; Dore GJ, 2004, 'Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort', AIDS, 18, pp. 1169 - 1177
2004
Ananworanich J; Cheunyam T; Teeratakulpisarn S; Boyd MA; Ruxrungtham K; Lange PJ; Cooper PD; Phanuphak PP, 2004, 'Creation of a drug fund for post-clinical trial access to antiretrovirals', Lancet, 364, pp. 101 - 102, http://dx.doi.org/10.1016/S0140-6736(04)16596-3
2004
Law WP; Dore GJ; Duncombe CJ; Mahanontharit A; Boyd MA; Ruxrungtham K; Lange JM; Phanuphak P; Cooper DA, 2003, 'Risk of severe hepatotoxicity associated with antiretroviral therapy in the HIV-NAT Cohort, Thailand, 1996-2001', AIDS, 17, pp. 2191 - 2199
2003
Burger D; Boyd M; Duncombe CJ; Felderhof M; Mahanontharit A; Ruxrungtham K; Ubolyam S; Stek M; Cooper DA; Lange JM; Phanuphak P; Reiss P, 2003, 'Pharmacokinetics and pharmacodynamics of indinavir with or without low-dose ritonavir in HIV-infected Thai patients', Journal of Antimicrobial Chemotherapy, 51, pp. 1231 - 1238
2003
Boyd MA; Zhang X; Dorr A; Ruxrungtham K; Kolis S; Nieforth K; Kinchelow T; Buss N; Patel IH, 2003, 'Lack of enzyme-inducing effect of rifampicin on the pharmacokinetics of enfuvirtide', Journal of Clinical Pharmacology, 43, pp. 1382 - 1391
2003
Boyd MA; Aarnoutse RE; Ruxrungtham K; Stek M; van Heeswijk RP; Lange JM; Cooper DA; Phanuphak P; Burger DM, 2003, 'Pharmacokinetics of indinavir/ritonavir (800/100 mg) in combination with efavirenz (600 mg) in HIV-1-infected subjects', Journal of Acquired Immune Deficiency Syndrome, 34, pp. 134 - 139
2003
Stretton B; Kovoor JG; Gupta AK; Ovenden C; Litwin P; Maddern GJ; Boyd M, 2022, Making up for Lost Time: Perioperative Direct Oral Anticoagulant Assay Measurements, , http://dx.doi.org/10.22541/au.166723035.55498329/v1
2022
Lau A; Kong F; Fairley C; Templeton D; Amin J; Phillips S; Law M; Chen M; Bradshaw C; Donovan B; McNulty A; Boyd M; Timms P; Chow E; Regan D; Khaw C; Lewis D; Kaldor J; Ratnayake M; Carvalho N; Hocking J, 2021, 'O11.2 Treatment efficacy of 1g azithromycin versus 100mg doxycycline bi-daily for seven days for asymptomatic rectal Chlamydia trachomatis', in STI treatment, BMJ Publishing Group Ltd, presented at Abstracts for the STI & HIV World Congress, July 14–17 2021, http://dx.doi.org/10.1136/sextrans-2021-sti.111
2021
Gartner C; Boyd M; Bonevski B; Gilks C; Borland R; Courtney R; Cobiac L; McRobbie H; Baker P; Mueller J, 2018, 'CESSATION AND RELAPSE PREVENTION TRIAL: VAPORISED NICOTINE PRODUCTS FOR PEOPLE ON OPIATE SUBSTITUTION THERAPY, OR WHO ARE LIVING WITH HEPATITIS C OR HIV', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S6 - S6, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449495000013&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2018
Khaw C; Raw L; Zablotska-Manos I; Boyd M, 2018, 'Chemsex: prevalence, characteristics and associated risk profiles of men who have sex with men in South Australia. A cross-sectional cohort study', in HIV MEDICINE, WILEY, pp. S46 - S46, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000430174700122&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2018
Holt SG; Gracey DM; Mudge DW; Irish AB; Sevastos J; Walker RG; Baer RA; Levy MT; Boyd MA, 2014, 'RENAL FUNCTION TESTING IN PATIENTS ON TENOFOVIR ANTIVIRAL THERAPY', in NEPHROLOGY, WILEY-BLACKWELL, pp. 72 - 72, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339715700206&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2014
Achhra AC; Boyd M; Law MG; Matthews G; Kelleher AD; Cooper DA, 2013, 'Sequencing antiretroviral therapy to maximize patient safety: could we move away from ritonavir, abacavir, tenofovir and efavirenz (RATE) - agents that concern prescribers and patients? A feasibility study and call for a trial', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, BELGIUM, Brussels, pp. A51 - A51, presented at 15th International Workshop on Co-morbidities and Adverse Drug Reaction in HIV, BELGIUM, Brussels, 15 October 2013 - 17 October 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335230200056&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2013
Chadwick M; Boyd MA; Cathers B, 1997, 'A water quality modelling tutorial using SIMULINK', in MODSIM 1997: International Congress on Modelling and Simulation, MODSIM 1997: International Congress on Modelling and Simulation, University of Tasmania, Hobart, presented at MODSIM 1997: International Congress on Modelling and Simulation, University of Tasmania, Hobart, 08 December 1997 - 11 December 1997
1997
Boyd MA; Cathers B; Chadwick M; Craig E, 1996, 'Developing a set of teaching exercises in ennvironmental engineering modelling', in 8th Australasian Association for Engineering Education Conference and Convention, 8th Australasian Association for Engineering Education Conference and Convention, University of New South Wales, presented at 8th Australasian Association for Engineering Education Conference and Convention, University of New South Wales, 15 December 1996 - 18 December 1996
1996
Boyd MA; Crowe SM, 2017, 'Indinavir', in Kucers the Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs, Seventh Edition, pp. 4061 - 4074, http://dx.doi.org/10.1201/9781315152110
2017
Boyd MA; Cooper DA, 2011, 'Antiretroviral agents', in Finch RG; Freenwood D; Whitley RJ; Norrby SR (ed.), Antibiotic and Chemotherapy: anti-infective agents and their use in therapy, edn. 9, Elsevier, London, pp. 472 - 493
2011
Boyd MA; Crowe SM, 2010, 'Indinavir', in Grayson ML; Crowe SM; McCarthy JS; Mills J; Mouton JW; Norrby SR; Paterson DL; Pfaller MA (ed.), Kucers' the use of antibiotics: A clinical review of antibacterial, antifungal, antiparasitic and antiviral drugs, edn. 6th, Hodder Arnold, London, pp. 2776 - 2787
2010
Boyd M; Cooper DA, 2010, 'Antiretroviral agents', in Antibiotic and Chemotherapy: Expert Consult, pp. 427 - 451, http://dx.doi.org/10.1016/B978-0-7020-4064-1.00036-1
2010
Berry M; Boyd MA, 2009, 'Infectious Diseases', in Fulde G (ed.), Emergency Medicine, the Principles of Practice, edn. 5th, Elsevier, Australia, pp. 640 - 664, http://shop.mja.com.au/
2009
Boyd MA; Cooper DA, 2008, 'Implementation of antiretroviral therapy in developing countries.', in Soriano V; Cooper DA (ed.), International HIV/AIDS Updates: Antiretroviral Therapy, edn. Original, Permanyer Publications, Barcelona, pp. 179 - 192
2008